Zhibin Liao
1095 Jiefang Avenue
Wuhan, 430030, China
Wuhan, 430030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
m6A-Mediated TMCO3 Promotes Hepatocellular Carcinoma Progression by Facilitating the Membrane Translocation and Activation of AKT.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 07, 2025
Targeting Tumor Stroma: Current Challenges and Future Directions.
Journal: MedComm
Published: January 25, 2025
Targeting TM4SF1 promotes tumor senescence enhancing CD8+ T cell cytotoxic function in hepatocellular carcinoma.
Journal: Clinical and molecular hepatology
Published: October 28, 2024
GPR56 facilitates hepatocellular carcinoma metastasis by promoting the TGF-β signaling pathway.
Journal: Cell death & disease
Published: April 20, 2024
m6A-Dependent ITIH1 Regulated by TGF-β Acts as a Target for Hepatocellular Carcinoma Progression.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 27, 2024
N6-methyladenosine reader YTHDF3-mediated zinc finger protein 41 inhibits hepatocellular carcinoma progression by transcriptional repression of Snail.
Journal: MedComm
Published: November 17, 2023
SP1-activated USP27X-AS1 promotes hepatocellular carcinoma progression via USP7-mediated AKT stabilisation.
Journal: Clinical and translational medicine
Published: September 08, 2023
Integrinβ-1 in disorders and cancers: molecular mechanisms and therapeutic targets.
Journal: Cell communication and signaling : CCS
Published: August 23, 2023
MYC in liver cancer: mechanisms and targeted therapy opportunities.
Journal: Oncogene
Published: July 17, 2023
EZH2 in hepatocellular carcinoma: progression, immunity, and potential targeting therapies.
Journal: Experimental hematology & oncology
Published: February 07, 2023
Last Updated: 09/26/2026